AZN
Astrazeneca·NYSE
--
--(--)
--
--(--)
4.22 / 10
Netural
Technical analysis gives AZN a 4.22/10 neutral rating. RSI is overbought (score 7.44) indicating short‑term upward pressure, while a MACD death cross (score 1) signals bearish momentum. Signals are balanced, suggesting volatility and no clear directional bias.
Analysis Checks(1/2)
RSI Overbought
Score7.44/10
Win Rate83.33%
Hist. Signals6
Avg Return0.48%
Score7.44/10
Win Rate83.33%
Hist. Signals6
Avg Return0.48%
MACD Death Cross
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-4.83%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-4.83%
RSI Overbought
Score7.44/10
Win Rate83.33%
Hist. Signals6
Avg Return0.48%
Score7.44/10
Win Rate83.33%
Hist. Signals6
Avg Return0.48%
MACD Death Cross
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-4.83%
Score1/10
Win Rate0.00%
Hist. Signals1
Avg Return-4.83%
Technical Analysis of AZN?
- AZN presents a Netural setup with a Technical Score of 4.22/10. Key technical indicators highlight an RSI of 35.38 and a MACD of -3.44, with the trend anchored by the 50-Day SMA at 0.00. Traders should monitor key support at 186.91 and resistance at 190.37.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
